Please provide your email address to receive an email when new articles are posted on . Novome Biotechnologies announced positive results of its phase 1 trial evaluating NOV-001, a once-daily ...

The second messenger cyclic dimeric guanosine monophosphate (c-di-GMP) induces wide-ranging physiological changes in diverse bacterial species, but how it controls the transcription and translation of ...

GEMM-based treatments could be used to produce signals in the gut that affect these remote systems or to generate metabolites small enough to traverse the gut mucosal barrier to circulate in the blood ...

Optica, the American Geophysical Union and the National University of Singapore partnered to bring together experts in climate, technology and policy for critical discussions. The first-of-its-kind ...